ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 628,57
-0,56%
Dow Jones
39 150,33
0,04%
DAX
18 163,52
-0,41%
Brent Oil
84,39
0,00%
Bitcoin
64 448,27
0,32%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Omthera Pharmaceuticals, Inc. (MM) (OMTH)

  7. Omthera Pharmaceuticals, Inc. (MM) (OMTH) Actualités

OMTH

OMTHERA PHARMACEUTICALS, INC. (OMTH)

Omthera Pharmaceuticals, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:OMTH
DateHeureSourceTitreSymboleSociété
18/07/201321h30Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
18/07/201321h30Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
18/07/201321h06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
18/07/201320h50Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
18/07/201317h39Edgar (US Regulatory)(25-NSE)NASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
16/07/201318h00PR Newswire (US)Omthera Stockholders Approve Acquisition by AstraZenecaNASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
11/07/201315h13Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
09/07/201312h00PR Newswire (US)Omthera Pharmaceuticals Announces NDA Submission for Epanova™ for the Treatment of Patients with Very High TriglyceridesNASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
27/06/201317h00PR Newswire (US)Omthera Pharmaceuticals Announces Termination Of Antitrust Waiting PeriodNASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
13/06/201318h54Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
13/06/201318h13PR Newswire (US)Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of StockholdersNASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
10/06/201311h20Dow Jones NewsAstraZeneca Buys Pearl for $1.15 BillionNASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
04/06/201323h12GlobeNewswire Inc.OMTHERA PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors of Claims of Breaches of Fiduciary Duty by BoardNASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
03/06/201323h37Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
31/05/201301h30Business WireRigrodsky & Long, P.A. Investigates Omthera Pharmaceuticals, Inc. BuyoutNASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
31/05/201300h01PR Newswire (US)Omthera Pharmaceuticals, Inc. Stockholders Seeking More Money, Information in Buyout Should Contact Deans & Lyons Law FirmNASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
30/05/201323h47Business WireSHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Omthera Pharmaceuticals, Inc.NASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
30/05/201322h28PR Newswire (US)OMTHERA PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Announces Investigation into Possible Breaches of Fiduciary Duty ...NASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
29/05/201322h39Business WireOmthera Pharmaceuticals Shareholder Alert: Briscoe Law Firm and Powers Taylor, LLP Investigate Sale to AstraZenecaNASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
29/05/201319h00PR Newswire (US)SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Omthera Pharmaceuticals, Inc - OMTHNASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
29/05/201318h06Business WireLaw Firm Brower Piven Announces Investigation of Omthera Pharmaceuticals, Inc. Proposed BuyoutNASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
29/05/201316h47PR Newswire (US)Ryan & Maniskas, LLP Announces Investigation of Omthera Pharmaceuticals, Inc.NASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
29/05/201313h13Business WireSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Omt...NASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
29/05/201303h11PR Newswire (US)Lifshitz Law Firm Announces Investigation of CapLease, Inc., Lender Processing Services, Inc., Omthera Pharmaceuticals, Inc. ...NASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
29/05/201303h00Business WireOMTHERA PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Omthe...NASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
29/05/201302h55PR Newswire (US)Harwood Feffer LLP Announces Investigation of Omthera Pharmaceuticals, Inc.NASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
29/05/201301h00Business WireFaruqi & Faruqi, LLP, Partner Juan E. Monteverde Launches an Investigation of Omthera Pharmaceuticals, Inc. (OMTH) Over the P...NASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
28/05/201323h11Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
28/05/201320h21Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
28/05/201318h11Edgar (US Regulatory)Semi-annual Report (management Company) (nsar-a)NASDAQ:OMTHOmthera Pharmaceuticals, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:OMTH

Dernières Valeurs Consultées

TG
A3KU99
Pfizer
AMEX
DEF
Invesco Defensive Equity...
USOTC
DRRKF
Dormakaba (PK)
DOWI
DWCFOD
DJ US Food Products Tota...
COIN
GODSUST
Gods Unchained
NASDAQ
FSWGX
Fidelity Advisor Sustain...
BOV
PETRR328
PETRR328 Ex:29,01
LSE
0KOC
Progressive
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés